Skip to content
OREPracticeGet Started

ORE Part 1 human disease questions

Human disease in ORE Part 1 sits in Paper A. Questions test general pathology and the dental management of medically compromised patients: whether to treat, modify care or refer under UK guidance.

Updated 1 October 2026 · Checked against the sources listed below

Human disease

3 of 8

  1. Question 3 · General pathology and immunology

    A 19-year-old man has acute pericoronitis around a partially erupted lower right third molar. The gum over it is red, warm to the touch and swollen, it is painful to touch, and he cannot open his mouth fully.

    Which one of the following sets names the five cardinal signs of acute inflammation that he shows?

What ORE Part 1 tests in human disease

The provider's blueprint lists two human disease topics among the eleven in Paper A. They are Human Disease relevant to dentistry and Oral aspects of human disease. It gives no weighting for any topic. Questions range from general pathology and immunology to the systemic diseases that change dental care. Many describe a patient's medical history and ask whether to treat as normal, modify the treatment or refer. The specification maps the GDC's Preparing for Practice outcome on managing the impact of medical conditions to Part 1. The GDC's Standards require an up-to-date medical history each time a patient is treated.

Treat, modify or refer: the UK rules

PatientThe decision a question testsUK source
High risk of infective endocarditis: previous endocarditis, a prosthetic valve or valve repair material, untreated cyanotic congenital heart disease, a ventricular assist deviceAntibiotic prophylaxis offered before extractions and oral surgery, and considered for procedures that manipulate the gingival or periapical tissues, as a shared decisionNICE CG64; SDCEP implementation advice
Moderate risk of infective endocarditis: rheumatic heart disease, a bicuspid aortic valve, an implanted cardiac electronic device such as a pacemakerNo prophylaxis unless the cardiac team has specified itSDCEP implementation advice
Bisphosphonates, denosumab or anti-angiogenic drugsRisk assessed and recorded as low or higher; straightforward extractions in primary care, with alternatives explored first at higher riskSDCEP MRONJ guidance
Haemophilia and other inherited bleeding disordersLiaison with the haemophilia centre; cover for an inferior dental block or lingual infiltration; most extractions in hospitalUKHCDO guidance
DiabetesAn increased risk of periodontal disease assumed for every patient with diabetes; periodontal treatment may improve diabetes controlDelivering Better Oral Health
Renal impairment, liver impairment and pregnancyIbuprofen avoided where possible in renal impairment and in severe hepatic impairment; in pregnancy avoided in the third trimester and in the first two unless essentialBNF

SDCEP's MRONJ guidance classes a patient as low risk when osteoporosis or another non-malignant bone disease is treated with bisphosphonates for less than 5 years, or with denosumab, without systemic glucocorticoids. Cancer patients are higher risk. Patients taking anticoagulant or antiplatelet drugs are covered on the pharmacology page with SDCEP's rules, and collapse in the chair on the medical emergencies page.

Where candidates go wrong

These traps come from the guidance behind the questions.

  • The MRONJ definition applied too early. MRONJ is exposed bone, or bone that can be probed through a fistula, in the maxillofacial region for more than eight weeks after antiresorptive or anti-angiogenic drugs, with no radiotherapy to the jaws and no obvious metastatic disease there. A socket exposed for six weeks does not meet it, and denosumab counts although it is not a bisphosphonate.
  • A drug holiday advised by the dentist. SDCEP finds no evidence that stopping bisphosphonates before treatment lowers the risk, because the drugs persist in bone for years. The decision belongs to the prescriber.
  • Antibiotics given to prevent MRONJ. SDCEP advises against antibiotic or antiseptic prophylaxis after extractions for this purpose. A socket that has not healed at eight weeks is referred.
  • Chlorhexidine offered instead of prophylaxis. NICE CG64 says chlorhexidine mouthwash should not be offered as prophylaxis against infective endocarditis.
  • An inferior dental block given by habit in haemophilia. Buccal infiltration can be used without cover for all upper teeth and for the buccal side of the lower incisors, canines and premolars.
  • A medical history taken once. The GDC requires it to be kept up to date each time the patient is treated.

How to revise human disease

Learn the topic by condition: the risk groups, what changes in the dental plan and the point at which care moves to a specialist. Then practise on scenarios, because a question gives the medical history and leaves the risk category to you. Read SDCEP's MRONJ guidance and its endocarditis implementation advice, which set out the risk groups that these questions turn on. The Paper A questions set human disease among the sciences, and the free diagnostic gives a first read on every subject.

Questions candidates ask

Paper A. The provider's blueprint lists Human Disease relevant to dentistry and Oral aspects of human disease among the Paper A topics. Special care and therapeutics are separate topics in Paper B.

NICE does not recommend routine prophylaxis for dental procedures and refers to SDCEP for patients at high risk. SDCEP advises offering prophylaxis before extractions and oral surgery to high-risk patients, such as those with a previous endocarditis or a prosthetic valve, as a shared decision. Patients at moderate risk, such as those with rheumatic heart disease or a bicuspid aortic valve, do not need it unless their cardiac team has specified it.

Yes. SDCEP's MRONJ guidance keeps straightforward extractions in primary care for low-risk and higher-risk patients, after a recorded risk assessment and valid consent. For higher-risk patients the alternatives to extraction are explored first, and no antibiotic or antiseptic prophylaxis is given to reduce the risk of MRONJ.

Only with cover arranged through the haemophilia centre. UK guidance for dental practitioners says clotting factor is usually needed only for an inferior dental block or a lingual infiltration. Buccal and intrapapillary infiltrations need no cover.

Sources

ORE Practice is independent of the General Dental Council. Rules, dates and fees can change: the GDC is the authority, and this page is checked against it.

Check human disease against the rest of Part 1

Human disease takes two of the eleven Paper A topics in the provider's blueprint. The free diagnostic asks 20 questions across Paper A and Paper B in about 15 minutes and gives a first read on every subject.

Take the free diagnostic

20 questions · about 15 minutes · free, no card details

WhatsApp an ORE teacher